LMO2 Antibodies

Santa Cruz Biotechnology provides a broad selection of LMO2 monoclonal antibodies for research applications in understanding LMO2 protein function. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LMO2, or LIM domain only 2, functions as a critical transcriptional regulator involved in hematopoiesis and lymphocyte development. Expression patterns of LMO2 undergo precise regulation during development and cellular differentiation. Dysregulation of LMO2 has been linked to various hematological malignancies, highlighting its significance in cancer research. Understanding LMO2 function provides valuable insights into mechanisms of tumorigenesis. Research focused on LMO2 continues to reveal new aspects of gene regulation in normal and disease states. Ongoing studies of LMO2 may lead to novel therapeutic approaches for blood cancers. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of LMO2 and its role in human health and disease.